About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Natco Pharma Commences Production At Dehradun Unit

by Medindia Content Team on June 27, 2006 at 2:56 PM
Font : A-A+

Natco Pharma Commences Production At Dehradun Unit

Natco Pharma Ltd today said it has commenced commercial production at its Dehradun unit.

The company informed the Bombay Stock Exchange that the finished dosage pharmacuetical formulations unit would achieve a capacity level of 300 million tablets per annum and the project is being implemented in stages.

Advertisement

Plans of establishing a parenterals division at Dehradun are also underway, it added.

The share of the company was trading at Rs 102.35, down 4.48 per cent on the BSE.

Source:PTI News
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test Your Knowledge About Chromosomes?
Eating During Sunlight Hours Minimizes Mood Vulnerabilities
Know More About the Digestive System
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity 

Most Popular on Medindia

Blood Pressure Calculator Indian Medical Journals How to Reduce School Bag Weight - Simple Tips Nutam (400mg) (Piracetam) Blood Donation - Recipients Drug - Food Interactions Sanatogen Color Blindness Calculator Selfie Addiction Calculator The Essence of Yoga
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Natco Pharma Commences Production At Dehradun Unit Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests